title: When should we start enzyme replacement therapy for infantile Pompe disease with severe cardiomyopathy?
authors.forename: Juan L
authors.initials: JL
authors.lastname: Bonilla-Palomas
authors.forename: Antonio L
authors.initials: AL
authors.lastname: Gámez-López
authors.forename: María A
authors.initials: MA
authors.lastname: Tejero-Hernández
authors.forename: Ignacio
authors.initials: I
authors.lastname: Tejero-Mateo
authors.forename: Juana
authors.initials: J
authors.lastname: López-López
mesh_terms: D009202:Cardiomyopathies / Q000188:drug therapy* / Q000209:etiology; D004452:Echocardiography; D004562:Electrocardiography; D056947:Enzyme Replacement Therapy / Q000379:methods*; D005260:Female; D006009:Glycogen Storage Disease Type II / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D011379:Prognosis; D011859:Radiography; D000520:alpha-Glucosidases / Q000627:therapeutic use
chemical_list: D000520:alpha-Glucosidases